Skip to main content
OpenTrials

Clinical trial condition

Newly Diagnosed Intermediate/High-Risk MDS

Explore clinical trials studying Newly Diagnosed Intermediate/High-Risk MDS. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Newly Diagnosed Intermediate/High-Risk MDS trial results

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Bone Marrow Diseases, +33 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Oncology Institute of Hope and Innovation Pasadena, California, United States
  • Rocky Mountain Regional VA Medical Center Aurora, Colorado, United States
  • Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) Denver, Colorado, United States
View all 46 locations